These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 544162)

  • 1. [Effects of proxazole on patients with obliterating arteriopathy of the lower limbs].
    Saponaro A; Russo R; Tomei F; Giordano M; Dragagna G; Barbato G
    Clin Ter; 1979 Dec; 91(6):585-92. PubMed ID: 544162
    [No Abstract]   [Full Text] [Related]  

  • 2. [Physical and exercise therapy of chronic obliterating arteriopathy of the lower limbs: clinical study].
    Galante M; Franchignoni F; Andina A; Grioni G
    Clin Ter; 1982 May; 101(4):357-62. PubMed ID: 7105641
    [No Abstract]   [Full Text] [Related]  

  • 3. Levodopa in the treatment of arterial insufficiency of the lower limbs. Clinical and rheographic trial.
    Vaccaro E; Solitro A; Barba C
    Arzneimittelforschung; 1973 Dec; 23(12):1793-8. PubMed ID: 4205907
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experiences with the treatment of peripheral vascular diseases with Xavin].
    Brücknerová O
    Vnitr Lek; 1973 Apr; 19(4):379-86. PubMed ID: 4699159
    [No Abstract]   [Full Text] [Related]  

  • 5. [Surheme in chronic obliterative arteriopathies of the lower limbs].
    Desruelles J; Waucampt JJ
    Lille Med; 1971 Jan; 16():Suppl 1:224-9. PubMed ID: 5162043
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intra-arterial infusion therapy in thrombo-obliterating diseases of the lower limbs].
    Kurbangaleev SM; Savel'ev IuS
    Vestn Khir Im I I Grek; 1974 Oct; 113(10):68-71. PubMed ID: 4432347
    [No Abstract]   [Full Text] [Related]  

  • 7. [Medium term treatment with suloctidil in obliterating arteriopathies of the lower limbs. Personal experience].
    Marongiu G; Dettori G; Gadeddu A; Noya G; Angius P; Biglioli P
    Minerva Cardioangiol; 1983; 31(7-8):407-10. PubMed ID: 6316206
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparison of 2 effective doses of Fludilat in peripheral vascular disorders in a double-blind trial].
    König FK
    Med Welt; 1973 Sep; 24(39):1490-2. PubMed ID: 4588974
    [No Abstract]   [Full Text] [Related]  

  • 9. [Medical treatment of obliterating arteriopathies of the lower limbs with vasoactive drugs].
    Raspanti D; Cameli AM; Trapani M; Dorigo D; Mazzotta A; Negro P
    Clin Ter; 1987 Jun; 121(6):479-83. PubMed ID: 2973884
    [No Abstract]   [Full Text] [Related]  

  • 10. [Action and tolerability of delayed-action buflomedil in obliterating arteriopathies of the lower limbs. A multicenter study].
    Andreozzi GM; Lepore R
    Clin Ter; 1990 Nov; 135(4):273-81. PubMed ID: 2150026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effect of O-betahydroxyethyl-rutosides (HR) in patients with occlusive arterial disease.
    Bielawiec M; Lukjan H; Grabowski R; Myśliwiec M; Korfel B
    Bibl Anat; 1977; (16 Pt 2):152-4. PubMed ID: 603503
    [No Abstract]   [Full Text] [Related]  

  • 12. [Gangliectomy in the treatment of obliterating arterial diseases of the lower extremities].
    Sitenko VM
    Vestn Khir Im I I Grek; 1979 Jun; 122(6):3-9. PubMed ID: 452296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in morning platelet aggregation in patients with peripheral obliterating arteriopathy after evening administration of picotamide].
    Craveri A; Colombo L; Cristina M; Coloru M; De Angeli B; Lanfredini M
    Clin Ter; 1991 Jan; 136(1):23-9. PubMed ID: 1826869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of suloctidil therapy on platelet function in patients with on obliterating arteriopathy of the lower limbs].
    Davì G; Pinto A; Novo S; Avellone G; Galati D; Mazzola A
    Clin Ter; 1982 Oct; 103(2):131-7. PubMed ID: 6295693
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ozone therapy, a new method of treating chronic obliterating arteriopathies].
    Ionescu G; Pitea P; Blaj A
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(3):207-13. PubMed ID: 2931752
    [No Abstract]   [Full Text] [Related]  

  • 16. [Systolic arterial hypertension: demonstration and mechanism in obliterating arteriopathy of the lower extremities].
    Temmar M; Benetos A; Simon A; Fiessinger JN; Levenson J; Safar M
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():163-6. PubMed ID: 6810820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Taurine in the therapy of obliterating arteriopathy of the lower extremities. I. Clinical results in various evolutive phases].
    Zanelli G; Ferrero S; Patrone P
    Minerva Cardioangiol; 1971 Nov; 19(11):605-15. PubMed ID: 5128422
    [No Abstract]   [Full Text] [Related]  

  • 18. [Medical therapy of chronic obstructive arteriopathy of the lower extremities. A controlled clinical study of suloctidil versus xanthinol].
    Spinella G; Majorana M
    Clin Ter; 1983 Mar; 104(5):375-81. PubMed ID: 6303677
    [No Abstract]   [Full Text] [Related]  

  • 19. [Assessment of the clinical effectiveness of actihaemyl in Fontaine stage IIb intermittent claudication].
    Horsch S; Claeys L; Diehm C; Rieger H; Cachovan M; Baitsch C
    Vasa Suppl; 1992; 37():64-5. PubMed ID: 1481105
    [No Abstract]   [Full Text] [Related]  

  • 20. [Stage II obliterating arteriopathy of the lower limbs. The problem of indications of reconstructive arterial surgery in patients with intermittent claudication].
    Deriu GP; Ballotta E; Maruotti R
    Minerva Cardioangiol; 1978 Nov; 26(11):743-5. PubMed ID: 724122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.